Science
Mechanism of Action
Nifedipine functions as a dihydropyridine calcium channel blocker, inhibiting L-type voltage-dependent calcium channel activity in vascular smooth muscle cells. This action prevents calcium ion entry, leading to the relaxation and expansion of blood vessels, thereby improving blood flow (vasodilation) in the skin. Enhanced microcirculation supports accelerated epithelization, neovascularization, modulation of extracellular matrix, and collagen synthesis, alongside stimulating growth factors like TGF-β, all contributing to wound healing. For anti-wrinkle effects, it is theorized to relax mimic muscular fibers, reducing wrinkle depth.
Research
Clinical Evidence
Medium confidence0.5%
Key findings
- 01 Demonstrated efficacy in reducing facial wrinkle depth, enhancing skin hydration and elasticity, and inducing overall skin lightening.
- 02 Promoted wound healing in rabbits by increasing TGF-β expression; notably, a 2% concentration did not yield a similar impact.
- 03 Mentioned in a patent as a concentration range for topical nifedipine formulations intended for conditions like Raynaud's phenomenon, chilblains, or wound healing.
Transparency
Dusting Analysis
Nifedipine is classified as a prescription pharmaceutical, not a cosmetic ingredient. Its listing under California's Prop 65 for developmental and reproductive toxicity, coupled with the potential for systemic absorption and associated side effects, means any concentration in a cosmetic product presents a significant regulatory and safety red flag.
The Formula
Formulation
Stability
Nifedipine is highly susceptible to light and undergoes rapid photodegradation, which can lead to inactivation and inconsistent efficacy. Formulations require protection from light, ideally stored in opaque containers at controlled room temperature (e.g., below 25°C). Photoprotectants such as 0.5% w/w quercetin or a combination of quercetin and avobenzone can enhance its photostability. The pH of compounded topical formulations typically shows minimal variation (less than 1 unit change).
Conflicts
- Light exposure (photodegradation)
Safety
Safety Profile
Nifedipine is primarily a prescription drug, FDA-approved for oral use in conditions like chronic stable angina and hypertension. Its topical formulations are typically custom-compounded pharmaceuticals for specific medical conditions, rather than generally classified cosmetic ingredients. It is listed under the California Safe Cosmetics Program (CSCP) Reportable Ingredients due to concerns regarding developmental and reproductive toxicity (Prop 65). It has not been reviewed for cosmetic use by the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS). Potential side effects of topical nifedipine, possibly due to systemic absorption, include flushing, headache, lightheadedness, and perianal itching.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite some evidence of skin benefits, Nifedipine's status as a prescription drug with significant safety concerns (including Prop 65 developmental/reproductive toxicity) and a lack of cosmetic regulatory review renders it unsuitable for inclusion in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…